Table 1.
Malaria-associated demographics of study participants for each site, by intervention period
| Site | Intervention period | Total observationsa | Suspected malaria (%) | Tested for malaria (%)b | Microscopy (%) | Positive test result (%)b |
|---|---|---|---|---|---|---|
| Walukuba | Jan 2009–Oct 2013 | 183,327 | 95,080 (51.9%) | 92,784 (97.6%) | 92,738 (99.9%) | 30,785 (33.2%) |
| Nov 2013–May 2017 | 111,506 | 27,483 (24.7%) | 26,051 (94.8%) | 24,360 (93.5%) | 9239 (35.5%) | |
| Jun 2017–Jul 2018 | 29,023 | 7733 (26.6%) | 7024 (90.8%) | 5227 (74.4%) | 2037 (29.0%) | |
| Kasambya | Jan 2009–Nov 2013 | 85,200 | 65,768 (77.2%) | 63,479 (96.5%) | 60,070 (94.6%) | 24,538 (38.7%) |
| Dec 2013–Nov 2017 | 60,488 | 41,823 (69.1%) | 38,328 (91.6%) | 30,199 (78.8%) | 15,996 (41.7%) | |
| Dec 2017–Jul 2018 | 8123 | 5272 (64.9%) | 5083 (96.4%) | 1156 (22.7%) | 1529 (30.1%) | |
| Aduku | Jan 2009–Aug 2010 | 34,596 | 19,024 (55.0%) | 17,877 (94.0%) | 17,877 (100%) | 9921 (55.5%) |
| Sep 2010–Apr 2014 | 71,329 | 40,428 (56.7%) | 40,277 (99.6%) | 39,056 (97.0%) | 9825 (24.4%) | |
| May 2014–May 2017 | 66,092 | 34,467 (52.2%) | 29,410 (85.3%) | 17,466 (59.4%) | 15,311 (52.1%) | |
| Jun 2017–Jul 2018 | 25,389 | 9013 (35.5%) | 8158 (90.5%) | 2280 (28.0%) | 2189 (26.8%) | |
| Nagongera | Jan 2009–Nov 2013 | 124,711 | 82,762 (66.4%) | 76,915 (92.9%) | 74,959 (97.5%) | 27,007 (35.1%) |
| Dec 2013–Jan 2015 | 24,530 | 15,893 (64.8%) | 15,723 (98.9%) | 14,874 (94.6%) | 3977 (25.3%) | |
| Feb 2015–Jul 2018 | 72,236 | 27,297 (37.8%) | 27,064 (99.2%) | 16,213 (59.9%) | 4309 (15.9%) |
aPatients seen at the health facility excluding those with a missing record of age
bTesting for malaria includes both microscopy and RDT